---
layout: post
title: "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Reopening of the Comment Period"
date: 2026-02-05 18:35:38 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-03385
original_published: 2023-02-17 00:00:00 +0000
significance: 8.00
---

# Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Reopening of the Comment Period

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** February 17, 2023 00:00 UTC
**Document Number:** 2023-03385

## Summary

The Food and Drug Administration (FDA or Agency) is reopening the comment period for the notice entitled "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry," published in the Federal Register of November 18, 2022. The Agency is taking this action to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/02/17/2023-03385/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-reopening-of-the-comment)
- API: https://www.federalregister.gov/api/v1/documents/2023-03385

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
